# 5-Hydroxymethylfurfural Alleviates Lipopolysaccharide-Induced Depression-like Behaviors by Suppressing Hypothalamic Oxidative Stress and Regulating Neuroinflammation in Mice

**Authors:** Bailiu Ya, Haiyan Yin, Lili Yuan, Aihong Jing, Yuxuan Li, Fenglian Yan, Hui Zhang, Huabao Xiong, Mingsheng Zhao

PMC · DOI: 10.3390/antiox14111366 · 2025-11-17

## TL;DR

5-HMF reduces depression-like behaviors in mice by reducing brain inflammation and oxidative stress, offering potential as a treatment for inflammation-related depression.

## Contribution

This study reveals the antidepressant mechanisms of 5-HMF through Nrf2 pathway activation and microglial regulation in an LPS-induced depression model.

## Key findings

- 5-HMF alleviated LPS-induced depression-like behaviors and reduced hypothalamic neuronal damage.
- It decreased oxidative stress and inhibited microglial M1 polarization, regulated inflammatory cytokines, and activated the Nrf2 pathway.
- The effects of 5-HMF were significantly reduced by the Nrf2 inhibitor brusatol, confirming the pathway's role.

## Abstract

5-hydroxymethylfurfural (5-HMF) has been shown to exert neuroprotective effects in a global cerebral ischemia mouse model in our previous study, where it demonstrated antioxidant and anti-inflammatory properties. However, studies on its antidepressant mechanisms remain scarce. Since oxidative stress and neuroinflammation are closely associated with depression, this study investigated the antidepressant effects of 5-HMF, focusing on its potential inhibition of oxidative stress via the Nrf2 pathway and its role in microglial M1 polarization-mediated neuroinflammation. An acute depression mouse model induced by intraperitoneal injection of lipopolysaccharide (LPS) was utilized. Mice received 5-HMF (12 mg/kg) or an equal volume of vehicle via intraperitoneal injection 30 min prior to and 5 min after LPS administration. At 24 h post-modeling, behavioral tests (sucrose preference, forced swim, and open field tests) were conducted to evaluate the antidepressant effect of 5-HMF. Histological damage in the hypothalamus was assessed using Nissl staining and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining. Immunofluorescence was performed to evaluate M1 polarization of hypothalamic microglia. Oxidative stress damage was assessed by measuring malondialdehyde (MDA), carbonyl groups, and 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels. Nrf2 DNA-binding activity was examined using an ELISA-based assay. The expression of inflammatory cytokines, Nrf2, and downstream antioxidant proteins was analyzed by ELISA kits and Western blotting. 5-HMF significantly alleviated LPS-induced depression-like behaviors, reduced hypothalamic neuronal damage, decreased oxidative stress, and inhibited microglial M1 polarization. It also regulated the expression of inflammatory cytokines (IL-1β, IL-6, TNF-α, IL-4, and IL-10) and activated the Nrf2 signaling pathway, enhancing nuclear translocation efficiency. Notably, these effects were significantly attenuated by the Nrf2 inhibitor brusatol. In conclusion, 5-HMF exerts neuroprotective effects by modulating Nrf2-mediated oxidative stress responses and suppressing microglial M1 polarization-driven neuroinflammation. These findings suggest that 5-HMF may provide therapeutic potential for alleviating depression symptoms induced by acute inflammation.

## Linked entities

- **Proteins:** GABPA (GA binding protein transcription factor subunit alpha), IL1B (interleukin 1 beta), IL6 (interleukin 6), TNF (tumor necrosis factor), IL4 (interleukin 4), IL10 (interleukin 10)
- **Chemicals:** 5-hydroxymethylfurfural (PubChem CID 237332), 5-HMF (PubChem CID 237332), brusatol (PubChem CID 73432), malondialdehyde (PubChem CID 10964), 8-hydroxy-2′-deoxyguanosine (PubChem CID 135406132), 8-OHdG (PubChem CID 135440064)
- **Diseases:** depression (MONDO:0002050)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** Depression (MESH:D003866), Neuroinflammation (MESH:D000090862), cerebral ischemia (MESH:D002545), acute depression (MESH:D000208), inflammation (MESH:D007249), neuronal damage (MESH:D009410)
- **Chemicals:** sucrose (MESH:D013395), dUTP (MESH:C027078), MDA (MESH:D008315), LPS (MESH:D008070), brusatol (MESH:C020237), 5-HMF (MESH:C008046), 8-OHdG (MESH:D000080242)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12649576/full.md

---
Source: https://tomesphere.com/paper/PMC12649576